HOME >> BIOLOGY >> NEWS
New Drug "Cocktails" Prove Effective Against Hepatitis

Research Also Links New Virus and Unexplained Liver Disease

CHICAGO, November 9 - At The American Association for the Study of Liver Diseases 1998 Annual Meeting in Chicago, November 6 - 10, some of the world's top biomedical researchers unveiled studies of drug therapies that are offering new hope in the fight against Hepatitis B and C. Another study examined the role of a newly discovered virus in liver disease.

HIV Drug Lamivudine Helps Hepatitis B Patients When Interferon Can't

At the AASLD Annual Meeting, Eugene Schiff, MD, University of Miami, discussed a study of the effects of a new drug, Lamivudine, that was given to chronic Hepatitis B patients who had previously failed Interferon therapy. There are many such patients, because Interferon is effective only 30%-40% of the time. Lamivudine, a drug that has been used to treat HIV patients, can be taken orally unlike Interferon, which must be injected every day. The study found that patients who took Lamivudine did much better than those who took a placebo, or who took Lamivudine in combination with Interferon. All those who took the new drug alone depressed the level of Hepatitis B virus in their bodies. Almost three quarters cleared the virus, either permanently or as long as they kept taking the drug "All in all, Lamivudine appears safe and effective," said Schiff. "In the future, I expect it will be used in combination with other drugs as part of an overall treatment of chronic Hepatitis B patients."

Interferon alfa-2b +ribavirin vs. Hepatitis C - Three Studies

Three studies on treatment of chronic Hepatitis C, reported at the AASLD Annual Meeting, found that acombination of Interferon alfa-2b and ribavirin (Rebetol) was dramatically effective. John McHutchison, MD, of Scripps Clinic and Research Foundation, reported on one study of more than 900 chronic Hepatitis C patients who had not had antiviral therapy before. Half the patients were give
'"/>

Contact: Kirk Monroe
kirkmonroe@aol.com
202-789-2892
American Association For The Study of Liver Diseases
9-Nov-1998


Page: 1 2 3

Related biology news :

1. Proven method of bone analysis may clarify human origins
2. Researchers Prove Chemoprevention Can Work
3. Drug Combination May Prove Effective To Prevent Recurrence Of Hepatitis C After Transplantation
4. Penn Researchers Prove "Short-Cut" Function Of Myelin Sheath Channel: BetterUnderstanding Of Myelin Should Lead To Therapies For Neuropathies
5. Reengineered Poliovirus Proves Effective As Vector For Prompting Key Immune Response In A Study With Mice
6. Simplified Therapy To Prevent TB Proven Effective In Developing Countries
7. High Levels of Vitamin C Prove Toxic to HIV
8. Effective acne treatments remain elusive, Hopkins researchers find
9. Study Ensures Effective Ways To Measure Macular Pigment Density
10. Discovery Of 13 Genes Expressed In Brain Tumors May Lead To More Effective Diagnosis Or Prevention
11. New Drug Shown Effective Against Vancomycin-Resistant Bacteria

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2019)... ... May 30, 2019 , ... ... company, and Mayo Clinic, have documented significant differences in the prevalence of hereditary ... ethnic populations compared to non-Hispanic White women. Results will be presented at the ...
(Date:5/26/2019)... ... ... Zolgensma (Novartis, AveXis), an AAV-delivered gene therapy used to treat spinal muscular atrophy (SMA) ... the Food and Drug Administration today. , The treatment is now both ... States and the second-ever approved treatment for SMA. , FDA granted priority review status ...
(Date:5/23/2019)... ... 23, 2019 , ... Inference Solutions , a global ... announced its inclusion in DMG Consulting’s 2019-2020 Intelligent Virtual Agent Product and Market ... share leader, based on number of customers, with 15.8% share of the global ...
Breaking Biology News(10 mins):
(Date:5/14/2019)... ... May 14, 2019 , ... Gateway Genomics , a leading developer ... from 2,500 to 5,000 square feet. , “This past year has seen exponential ... Gateway Genomics CEO, Chris Jacob. “The SneakPeek At-Home test, which is mailed directly to ...
(Date:5/4/2019)... ... May 03, 2019 , ... ... of the Diopsys® ffERG/Photopic Negative Response vision test, a new full ... 2050, it is estimated that 6.3 million Americans will have glaucoma, with black ...
(Date:5/2/2019)... ... May 02, 2019 , ... ... will present results documenting discrepancies between U.S. insurer policies for genetic testing and ... risk for hereditary breast and ovarian cancer (HBOC). , Jill S. ...
(Date:4/18/2019)... Mass. (PRWEB) , ... April 18, 2019 , ... ... fossil fuels, a research team that includes a chemical engineer at Worcester Polytechnic ... exotic microorganism that may make it possible to manufacture isobutanol and other biofuels ...
Breaking Biology Technology:
Cached News: